FDANonrulemakingFDA-2010-N-0449

Who commented on this docket

Risks and Benefits of Lon-Term Use of Nicotine Replacement Therapy Produts; Public Workshowp; Request for Comments

1 organizations filed 1 public comment on Risks and Benefits of Lon-Term Use of Nicotine Replacement Therapy Produts; Public Workshowp; Request for Comments, at the Food and Drug Administration. The comment window closed 5692d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 5692d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.